Find your next paid study

University of Illinois at ChicagoNCT06002919

Phase 2

Study To Assess Response to Eptacog Beta iN Patients With Glanzmann THromboasthenia (STRENGTH )

This study is evaluating an investigational drug, eptacog beta (EB), for the treatment and prevention of acute bleeding episodes in people with Glanzmann Throm…

Glanzmann Thrombasthenia

Emory UniversityNCT07136857

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

Building upon the results of a single-arm trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulat…

Cancer

University of California, IrvineNCT06338475

Temporal Interference Methods for Non-invasive Deep Brain Stimulation

In its totality, this grant aims to develop a line of research using temporal interference (TI) electrical neurostimulation technology to understand the causal…

Healthy Volunteers

Indiana UniversityNCT07339072

Phase 3

A Prospective Randomized Study Comparing the Outcome of Electrical Stimulation of Vastus Medialis Obliquus Muscle and Physical Therapy Vs Only Physical Therapy but No Electrical Stimulation in Patients with Patellofemoral Pain Syndrome

The purpose of study is to evaluate the efficacy of the electrical muscle stimulation (EMS) device in patients with patellofemoral pain known as anterior knee …

Patellofemoral Pain Syndrome

Northwell HealthNCT03184545

~$10 – $7,500

Phase 2

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)

Focal Seizure

Praxis Precision MedicinesNCT06999902

~$10 – $7,500

Phase 1

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and eso…

Colorectal CancerPancreatic CancerEsophageal Cancer+1 more

Lumicell, Inc.NCT02584244

~$10 – $8,750

Phase 3

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis

This is a multicenter, prospective, randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of intra-articular administration of PTP-001 (MOT…

Knee Osteoarthritis

Doron Therapeutics Inc.NCT07219771

~$10 – $8,750

Migraine DisordersRefractory MigraineChronic Migraine

Enduring Migraine Benefit From Responsive Artery Coil Embolization (EMBRACE): A Single-Site, Non-Significant Risk Pilot Study of Middle Meningeal Artery Embolization Using FDA-Cleared Coils for Refractory Episodic Migraine

This single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine…

Cortex NeurovascularNCT07313800

~$10 – $7,500

CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation

The goal of lower limb rehabilitation after stroke is recovery of independent walking at home and in the community. Few stroke survivors achieve this goal. Sub…

StrokeHemiplegia

Marquette UniversityNCT06329765

Phase 3

Intrathecal Administration of MELPIDA (AAV9/AP4M1) For Hereditary Spastic Paraplegia Type 50 (SPG50): A Phase 3, Open-Label Trial With Matched Prospective Concurrent Control Arm

Phase 3, open-label study to assess the efficacy and safety of a single lumbar intrathecal administration of MELPIDA in individuals with Hereditary Spastic Par…

Hereditary Spastic Paraplegia Type 50